Relief Therapeutics's subsidiary agrees to acquire worldwide commercialization rights of a novel dosage form for the treatment of PKU
March 15 2022 - 4:58AM
Seeking Alpha
To read the full story on Seeking Alpha, click
here.
Relief Therapeutics (QB) (USOTC:RLFTF)
Historical Stock Chart
From Aug 2024 to Sep 2024
Relief Therapeutics (QB) (USOTC:RLFTF)
Historical Stock Chart
From Sep 2023 to Sep 2024